Company · CIK 0001722964
Y-mAbs Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-25-090232 · 317.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-25-010848 · 11.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-010846 · 656.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-25-073993 · 1.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001104659-25-068099 · 201.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001104659-25-053289 · 10.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-25-007492 · 9.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-007491 · 522.3 KBSEC(opens sec.gov)
- 10-K/AY-mAbs Therapeutics, Inc.0001104659-25-040396 · 1.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-25-002174 · 596.4 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
202 CARNEGIE CENTER SUITE 301
PRINCETON, NJ, 08540
mailing
202 CARNEGIE CENTER SUITE 301
PRINCETON, NJ, 08540
Same industry